ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 823

Seasonal Variation in Giant Cell Arteritis and Polymyalgia Rheumatica Hospitalizations: Data from Nationwide Inpatient Sample

Paras Karmacharya1, Dilli Poudel2, Pragya Shrestha3, Rashmi Dhital4 and Raju Khanal4, 1Division of Rheumatology, Mayo Clinic, Rochester, MN, 2Internal Medicine, Reading Health System, WEST READING, PA, 3Internal medicine, Reading Health System, West Reading, PA, 4Internal Medicine, Reading Health System, West Reading, PA

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: giant cell arteritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 5, 2017

Title: Vasculitis Poster I: Large Vessel Vasculitis

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Most studies looking at seasonal variations in giant cell arteritis (GCA) note a seasonal trend, but show disparity on timing. Concurrent peaks of GCA and polymyalgia rheumatica (PMR) have been described by some studies questioning a common precipitating agent. We aimed to analyze the seasonal variation of GCA and PMR in the US using a large inpatient database.

Methods: We used Nationwide Inpatient Sample (NIS) database to identify patients aged ≥ 18 years from 2009-11 with a diagnosis of GCA and PMR with ICD-9-CM codes 446.5 and 725 in the first 3 positions. We used the Edwards’ recognition and estimation of cyclic trend method to study the seasonal patterns of GCA and PMR hospitations stratified by age. Z-test was used to compare seasonal incidences

Results:

A total of 57728 and 242862 hospitalizations with a diagnosis of GCA and PMR respectively were reported from 2009-11. A significant seasonal variation was observed with highest number of GCA hospitalizations in summer (peak/low ratio 1.092, 95% CI 1.067-1.118, p<0.0001) and most significant peaks seen in age group 65-69 (peak/low ratio 1.092, 95% CI 1.067-1.118, p<0.0001) (Figure 1). No significant seasonal variation was seen with PMR hospitalizations.

Conclusion:

Our study found peak GCA hospitalizations in summer months which is concurrent with trends seen in Israel and England but differ from other studies showing peaks in late winter and autumn. Interestingly, no similar pattern was observed in closely related disorder, PMR. A better understanding of these patterns could lead to identification and possibly control of potential environmental triggers in the genetically predisposed population.

Figure 1. Graph showing seasonal trend for GCA and PMR, 2009-2011


Disclosure: P. Karmacharya, None; D. Poudel, None; P. Shrestha, None; R. Dhital, None; R. Khanal, None.

To cite this abstract in AMA style:

Karmacharya P, Poudel D, Shrestha P, Dhital R, Khanal R. Seasonal Variation in Giant Cell Arteritis and Polymyalgia Rheumatica Hospitalizations: Data from Nationwide Inpatient Sample [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/seasonal-variation-in-giant-cell-arteritis-and-polymyalgia-rheumatica-hospitalizations-data-from-nationwide-inpatient-sample/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/seasonal-variation-in-giant-cell-arteritis-and-polymyalgia-rheumatica-hospitalizations-data-from-nationwide-inpatient-sample/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology